Today, we are closer than ever to wiping out some of world's deadliest diseases for good. In the coming years and decades, we could eradicate polio and malaria and bring diseases like tuberculosis and HIV under control as manageable conditions.
By 2045, we could see the world eradicate polio and malaria. We could see the first new TB vaccine in a century, and even a cure for HIV. Imagine a future where suffering or dying from one of these diseases is unthinkable. If we tackle these challenges today, our children could live in that world tomorrow.
10M
people killed by infectious diseases per year
Why ending infectious diseases matters:
Infectious diseases still kill more than 10 million people a year and make hundreds of millions of people sick
Today, we are closer than ever to wiping out some of these diseases for good.
Our goal is to ensure the next generation grows up safe from deadly disease.
How we work to end infectious disease
Polio
We make grants to partners and contribute technical and financial resources to develop more effective vaccines, expanding routine immunizations, improve polio surveillance and outbreak response, and more.
We have devoted resources and expertise to a relentless pursuit of malaria eradication. We support efforts to reduce the burden of malaria, accelerate progress toward eradication, and get ahead of drug and insecticide resistance.
Our tuberculosis team aims to address key gaps along the TB care pathway through new approaches to protecting against infection, preventing progression from infection to disease, and improving diagnosis and treatment.
We focus our efforts in some of the countries hardest hit by HIV in sub-Saharan Africa, particularly among populations that are at greatest risk of infection, including adolescent girls and young women.
Entomologist James Austin helped create the Interceptor G2, a next-generation insecticide-treated bed net designed to outsmart insecticide-resistant mosquitoes and protect families from malaria.
This explainer shows you the complete lifecycle of vaccine development, highlighting why success starts with management from the very beginning of vaccine research and testing to the end with manufacturing and delivery.
As TB overtakes COVID as the deadliest global disease, this article explores the history of vaccines and how key lessons can inform new TB vaccine development led by scientific leaders in Africa.
The Global Fund has helped save an estimated 70 million lives since 2002. Learn why continued investment is critical to maintaining progress in global health.
Cynthia MwaseDirector, Health, Africa, Mabulle
Explore stories from the field
Subscribe to The Optimist to get weekly updates on the latest in global health, gender equality, education, and more.
Polio
